SetPoint Medical today announced the first patients in Chicago have been treated with the SetPoint System, an FDA-approved neuroimmune modulation therapy for adults living with moderately-to-severely ...

Setpoint’s acquisition of inTENT Fulfillment will add experienced leaders and broaden ratings agency approvals for its asset-backed finance platform. AI Summary Setpoint, an operating system for asset ...

Setpoint, the operating system for asset-backed finance, today announced that it has signed an agreement to acquire inTENT Fulfillment, a specialized loan diligence and transaction management firm ...

Publication of 12-month outcomes reinforces SetPoint Medical’s pioneering role in advancing neuroimmune modulation as a new treatment paradigm for rheumatoid arthritis (RA) SetPoint Medical, a company ...

American corporations SetPoint Medical announced on 31st (local time) that its electroceutical for treating rheumatoid arthritis has received Food and Drug Administration (FDA) approval.

Fresh after getting the green light from the U.S. Food and Drug Administration, SetPoint Medical raises $140 million to market and distribute its rheumatoid arthritis treatment. SetPoint Medical Chief ...

SetPoint Medical, a Valencia-based company dedicated to developing therapies for people living with chronic autoimmune diseases, raised $140 million in private financing that includes $25 million in ...

SetPoint Medical has secured $140m through private financing, earmarked for the commercial rollout of the SetPoint System, a neuroimmune modulation therapy designed for patients with ...

Shortly after obtaining a green light from the FDA, SetPoint Medical announced $140 million in new funding to juice the commercialization of its neuromodulation implant for rheumatoid arthritis. The ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. SetPoint Medical said Monday that it raised $140 million ...

The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA). The ...

SetPoint Medical has raised $140 million. This includes $25 million in the second tranche of its Series C financing, as well as $115 million in its Series D financing, co-led by Elevage Medical ...